Skip to main content
Industry News
J&J pauses trials of COVID-19 vaccine

Johnson & Johnson said it has temporarily halted clinical trials of its COVID-19 vaccine candidate to allow investigation of an unexplained illness in one participant. The company said the patient's condition is being evaluated by its clinical and safety experts and an independent data and safety monitoring board.

Full Story: